Directa Plus granted two new patients in Italy, China to use G+ graphene technology

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Directa Plus was granted two new patents in Italy and China to use its propriety G+ graphene technology to make golf balls and nanoplatelets, respectively.

The first was an Italian patent for the use of the company's G+ graphene to make golf balls, while the second , a Chinese patent, which would cover Directa Plus' process to make graphene nanoplatelets.

The use of the G+ compounds in golf balls, can 'provide a series of beneficial features that offer opportunities to develop a new generation of golf ball, both for professional and amateur players,' the company said.

Directa Plus' process to produce graphene nanoplatelets can be tailor-made to meet customers' needs, and the high-yields create competitive prices, the company said.

At 9:24am: (LON:DCTA) Directa Plus Plc share price was +3.5p at 85p